All Stories

  1. Microsampling for antidepressant drug analysis: Current state and perspectives
  2. Synthetic Cathinones: Analytical Strategies, Pitfalls and Priorities for Forensic and Clinical Toxicology
  3. Vaginal Lactobacillus gasseri biosurfactant: a novel bio- and eco-compatible anti-Candida agent
  4. ANALYTICAL APPROACHES FOR THE IDENTIFICATION AND QUANTITATION OF NITAZENES: A REVIEW
  5. Volumetric absorptive microsampling for lumateperone analysis: method validation and stability evaluation
  6. In situ-generated volumetric dried plasma spots for the analysis of edaravone and metabolites in animal models
  7. Exposure of dams to Elexacaftor/ Tezacaftor/Ivacaftor during pregnancy and breastfeeding induces reversible alterations in newborn wild type CD-1 mice
  8. Volumetric absorptive microsampling for in vitro metabolism of the recent synthetic cannabinoid receptor agonist 5F-PB-22
  9. Review: the role of automation in improving the performance and throughput of microsample bioanalysis
  10. Quantitative urine spot microsamples for the chiral analysis of clenbuterol by capillary electrokinetic chromatography
  11. New trends in bioanalysis sampling and pretreatment: How modern microsampling is revolutionising the field
  12. Innovative Solid-Phase Extraction Strategies for Improving the Advanced Chromatographic Determination of Drugs in Challenging Biological Samples
  13. Volumetric absorptive microsampling for the therapeutic drug monitoring of psychiatric patients treated with cariprazine
  14. Evaluation of the Antioxidant Capacity of Fruit Juices by Two Original Analytical Methods
  15. Volumetric Absorptive Microsampling (VAMS) for Targeted LC-MS/MS Determination of Tryptophan-Related Biomarkers
  16. Green analytical chemistry (GAC) applications in sample preparation for the analysis of anthocyanins in products and by-products from plant sources
  17. Ion-Channel Antiepileptic Drugs: An Analytical Perspective on the Therapeutic Drug Monitoring (TDM) of Ezogabine, Lacosamide, and Zonisamide
  18. Enhanced urinary stability of peptide hormones and growth factors by dried urine microsampling
  19. Discriminating different Cannabis sativa L. chemotypes using attenuated total reflectance - infrared (ATR-FTIR) spectroscopy: A proof of concept
  20. Free and Conjugated Phenolic Profiles and Antioxidant Activity in Quinoa Seeds and Their Relationship with Genotype and Environment
  21. Clinopodium tomentosum (Kunth) Govaerts Leaf Extract Influences in vitro Cell Proliferation and Angiogenesis on Primary Cultures of Porcine Aortic Endothelial Cells
  22. QUANTITATIVE MICROSAMPLING FOR BIOANALYTICAL APPLICATIONS RELATED TO THE SARS-CoV-2 PANDEMIC: USEFULNESS, BENEFITS AND PITFALLS
  23. Fruit Quality Characterization of New Sweet Cherry Cultivars as a Good Source of Bioactive Phenolic Compounds with Antioxidant and Neuroprotective Potential
  24. Analytica—A Journal of Analytical Chemistry and Chemical Analysis
  25. Dried Urine Microsampling Coupled to Liquid Chromatography—Tandem Mass Spectrometry (LC–MS/MS) for the Analysis of Unconjugated Anabolic Androgenic Steroids
  26. Microsampling and LC–MS/MS for antidoping testing of glucocorticoids in urine
  27. Metabolic Syndrome in Schizophrenia: Focus on the Role of Antipsychotic Medications and Indications for Therapeutic Drug Monitoring (TDM) Methods
  28. New-generation, non-SSRI antidepressants: Drug-drug interactions and therapeutic drug monitoring. Part 2: NaSSAs, NRIs, SNDRIs, MASSAs, NDRIs, and others
  29. Blood and Plasma Volumetric Absorptive Microsampling (VAMS) Coupled to LC-MS/MS for the Forensic Assessment of Cocaine Consumption
  30. Assessment of capillary volumetric blood microsampling for the analysis of central nervous system drugs and metabolites
  31. Changes in carotenoids, phenolic acids and antioxidant capacity in bread wheat doughs fermented with different lactic acid bacteria strains
  32. Analysis of Artemisia annua extracts and related products by high performance liquid chromatography-tandem mass spectrometry coupled to sample treatment miniaturisation
  33. An Original HPLC Method with Coulometric Detection to Monitor Hydroxyl Radical Generation via Fenton Chemistry
  34. In Vitro Anti-Inflammatory Effect of Salvia sagittata Ethanolic Extract on Primary Cultures of Porcine Aortic Endothelial Cells
  35. Perspectives and strategies for anti-doping analysis
  36. Tutorial: Volumetric absorptive microsampling (VAMS)
  37. Determination of oxycodone and its major metabolites in haematic and urinary matrices: Comparison of traditional and miniaturised sampling approaches
  38. New-Generation, Non-SSRI Antidepressants: Therapeutic Drug Monitoring and Pharmacological Interactions. Part 1: SNRIs, SMSs, SARIs
  39. Enantioseparation and determination of asenapine in biological fluid micromatrices by HPLC with diode array detection
  40. Integrated Evaluation of the Potential Health Benefits of Einkorn-Based Breads
  41. Metabolism of Drugs Used in the Therapy of Seizures: An Analytical Point of View. Part 1
  42. Analytical profiling of selected antioxidants and total antioxidant capacity of goji ( Lycium spp.) berries
  43. Dialyzability of Oxycodone and Its Metabolites in Chronic Noncancer Pain Patients with End-Stage Renal Disease
  44. TDM of novel antipsychotics
  45. Discontinued anxiolytic drugs (2009 – 2014)
  46. Evaluation of the pharmacokinetics, safety and clinical efficacy of ziprasidone for the treatment of schizophrenia and bipolar disorder
  47. Dried blood spot testing: a novel approach for the therapeutic drug monitoring of ziprasidone-treated patients
  48. A fast and feasible microextraction by packed sorbent (MEPS) procedure for HPLC analysis of the atypical antipsychotic ziprasidone in human plasma
  49. Evaluation of the pharmacokinetics, safety and clinical efficacy of sertraline used to treat social anxiety
  50. Recent trends in the analysis of amino acids in fruits and derived foodstuffs
  51. Monitoring of chronic Cannabis abuse: An LC–MS/MS method for hair analysis
  52. Quantitative Evaluation of Auraptene and Umbelliferone, Chemopreventive Coumarins in Citrus Fruits, by HPLC-UV-FL-MS
  53. Dried blood spots: Liquid chromatography–mass spectrometry analysis of Δ9-tetrahydrocannabinol and its main metabolites
  54. Selective Serotonin Reuptake Inhibitors (SSRIs): Therapeutic Drug Monitoring and Pharmacological Interactions
  55. Content of melatonin and other antioxidants in grape-related foodstuffs: measurement using a MEPS-HPLC-F method
  56. Fast analysis of amino acids in wine by capillary electrophoresis with laser-induced fluorescence detection
  57. Chiral analysis of amphetamines, methadone and metabolites in biological samples by electrodriven methods
  58. Determination of aloe emodin in Aloe vera extracts and commercial formulations by HPLC with tandem UV absorption and fluorescence detection
  59. Analysis of risperidone and 9-hydroxyrisperidone in human plasma, urine and saliva by MEPS-LC-UV
  60. Determination of topiramate in human plasma by capillary electrophoresis with indirect UV detection
  61. Metabolism of Benzodiazepine and Non-Benzodiazepine Anxiolytic-Hypnotic Drugs: an Analytical Point of View
  62. Analysis of cocaine and two metabolites in dried blood spots by liquid chromatography with fluorescence detection: A novel test for cocaine and alcohol intake
  63. Simultaneous HPLC-F analysis of three recent antiepileptic drugs in human plasma
  64. Fast CE analysis of adrenergic amines in different parts of Citrus aurantium fruit and dietary supplements
  65. Simultaneous HPLC determination of 14 tricyclic antidepressants and metabolites in human plasma
  66. Simultaneous analysis of diazepam and its metabolites in rat plasma and brain tissue by HPLC-UV and SPE
  67. Determination of duloxetine in human plasma by capillary electrophoresis with laser-induced fluorescence detection
  68. Enantioseparation of the antidepressant reboxetine
  69. Benzodiazepine Metabolism: An Analytical Perspective
  70. Quantitative analysis of cocaine in human hair by HPLC with fluorescence detection
  71. Separation and HPLC analysis of 15 benzodiazepines in human plasma
  72. New environmental sensitive system for colon-specific delivery of peptidic drugs
  73. Enantioselective analysis of amisulpride in pharmaceutical formulations by means of capillary electrophoresis
  74. Electrodriven methods for the enantioseparation of second-generation antidepressant drugs: An update
  75. Determination of vigabatrin in human plasma by means of CE with LIF detection
  76. Analysis of the second generation antidepressant venlafaxine and its main active metabolite O-desmethylvenlafaxine in human plasma by HPLC with spectrofluorimetric detection
  77. HPLC analysis of the novel antidepressant duloxetine in human plasma after an original solid-phase extraction procedure
  78. Determination of the antidepressant paroxetine and its three main metabolites in human plasma by liquid chromatography with fluorescence detection
  79. Simultaneous determination of methadone, buprenorphine and norbuprenorphine in biological fluids for therapeutic drug monitoring purposes
  80. Analysis of aromatic and terpenic constituents of pepper extracts by capillary electrochromatography
  81. Possible levomepromazine–clozapine interaction: Two case reports
  82. Sensitive and selective determination of glutathione in probiotic bacteria by capillary electrophoresis–laser induced fluorescence
  83. Determination of amphetamines in human urine by liquid chromatography with fluorimetric detection using a solid-phase extraction procedure
  84. Determination of homovanillic acid (HVA) in human plasma by HPLC with coulometric detection and a new SPE procedure
  85. Capillary electrophoretic analysis of the antibiotic vancomycin in innovative microparticles and in commercial formulations
  86. HPLC analysis of the second-generation antidepressant sertraline and its main metabolite N-desmethylsertraline in human plasma
  87. Fluoxetine Metabolism and Pharmacological Interactions: The Role of Cytochrome P450
  88. Enantioseparation and quality control of biperiden in pharmaceutical formulations by capillary electrophoresis
  89. Determination of the antidepressant mirtazapine and its two main metabolites in human plasma by liquid chromatography with fluorescence detection
  90. Advances in the enantioseparation of second-generation antidepressant drugs by electrodriven methods
  91. Separation and analysis of glycyrrhizin, 18β-glycyrrhetic acid and 18α-glycyrrhetic acid in liquorice roots by means of capillary zone electrophoresis
  92. Separation and analysis of the major constituents of cloves by micellar electrokinetic chromatography
  93. Enantioselective determination of the novel antidepressant mirtazapine and its active demethylated metabolite in human plasma by means of capillary electrophoresis
  94. Rapid analysis of olanzapine and desmethylolanzapine in human plasma using high-performance liquid chromatography with coulometric detection
  95. Simultaneous liquid chromatographic analysis of catecholamines and 4-hydroxy-3-methoxyphenylethylene glycol in human plasma
  96. Atypical Antipsychotics: Pharmacokinetics, Therapeutic Drug Monitoring and Pharmacological Interactions
  97. Micelles Based on Polyvinyl Alcohol Substituted with Oleic Acid for Targeting of Lipophilic Drugs
  98. High-performance liquid chromatographic determination of Levetiracetam in human plasma: comparison of different sample clean-up procedures
  99. Analysis of plasma catecholamines by liquid chromatography with amperometric detection using a novel SPE ion-exchange procedure
  100. Enantiomeric separation of citalopram and its metabolites by capillary electrophoresis
  101. Quality control of commercial tablets containing the novel antipsychotic quetiapine
  102. Determination of melatonin in commercial preparations by micellar electrokinetic chromatography and spectrofluorimetry
  103. Liquid chromatographic analysis of the cis(Z)- and trans(E)-isomers of clopenthixol in human plasma using a novel solid phase extraction procedure
  104. Determination of recent antidepressant citalopram in human plasma by liquid chromatography—Fluorescence detection
  105. Determination of progesterone in commercial formulations and in non conventional micellar systems
  106. Liquid chromatographic determination of oxcarbazepine and its metabolites in plasma of epileptic patients after solid-phase extraction
  107. HPLC analysis of the novel antipsychotic drug quetiapine in human plasma
  108. Simultaneous analysis of six antiepileptic drugs and two selected metabolites in human plasma by liquid chromatography after solid-phase extraction
  109. Rapid methods for determination of fluoxetine in pharmaceutical formulations
  110. Determination of reboxetine, a recent antidepressant drug, in human plasma by means of two high-performance liquid chromatography methods
  111. Simultaneous high-performance liquid chromatography determination of carbamazepine and five of its metabolites in plasma of epileptic patients
  112. Rapid capillary electrophoretic method for the determination of clozapine and desmethylclozapine in human plasma
  113. A sensitive high-performance liquid chromatographic method using electrochemical detection for the analysis of olanzapine and desmethylolanzapine in plasma of schizophrenic patients using a new solid-phase extraction procedure
  114. Quantitation of olanzapine in tablets by HPLC, CZE, derivative spectrometry and linear voltammetry
  115. A rapid LC method for the identification and determination of CNS drugs in pharmaceutical formulations
  116. DEVELOPMENT OF AN HPLC METHOD FOR THE TOXICOLOGICAL SCREENING OF CENTRAL NERVOUS SYSTEM DRUGS
  117. Spectrophotometric determination of silicate traces in hemodialysis solutions
  118. Analytical methods for the quality control of Prozac® capsules
  119. Determination of fluoxetine and norfluoxetine in human plasma by high-pressure liquid chromatography with fluorescence detection
  120. Determination of clozapine in human plasma by solid-phase extraction and liquid chromatography with amperometric detection
  121. Comparison of analytical methods for quality control of pharmaceutical formulations containing glutathione